These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9279159

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.
    N Engl J Med; 1997 May 01; 336(18):1283-9. PubMed ID: 9113931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC, Maguiness KM, Hollingsworth J, Heilman DK, Chong SK.
    J Pediatr Gastroenterol Nutr; 1998 Jan 01; 26(1):80-4. PubMed ID: 9443125
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
    Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP.
    Lancet; 1994 Jan 08; 343(8889):85-6. PubMed ID: 7903780
    [Abstract] [Full Text] [Related]

  • 10. Fibrosing colonopathy in children with cystic fibrosis.
    Littlewood JM.
    Postgrad Med J; 1996 Mar 08; 72(845):129-30. PubMed ID: 8731700
    [No Abstract] [Full Text] [Related]

  • 11. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD.
    J Pediatr; 1994 Oct 08; 125(4):587-9. PubMed ID: 7931879
    [Abstract] [Full Text] [Related]

  • 12. Serum immunoglobulin G directed against porcine trypsin in the serum of cystic fibrosis children receiving porcine pancreatic enzyme supplements.
    Quirk P, Greer R, Shepherd R, Cleghorn G.
    J Paediatr Child Health; 1993 Jun 08; 29(3):196-200. PubMed ID: 8518002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concern about records of fibrosing colonopathy study.
    Dodge JA.
    Lancet; 2001 May 12; 357(9267):1526-7. PubMed ID: 11383534
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pancreatic enzymes and fibrosing colonopathy.
    Lloyd-Still JD, Beno DW, Uhing MR, Kimura RE.
    Lancet; 1999 Jul 17; 354(9174):251. PubMed ID: 10421325
    [No Abstract] [Full Text] [Related]

  • 19. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar 17; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 20. Serum immunoglobulin G directed against porcine trypsin in pancreatic insufficient cystic fibrosis patients receiving pancreatic enzyme supplements.
    Couper R, Lichtman S, Cleghorn G, del Castillo V, Durie P.
    Pancreas; 1991 Sep 17; 6(5):558-63. PubMed ID: 1946313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.